SYNTHEX

synthex-logo

SyntheX expands the druggable proteome using synthetic biology-driven drug discovery platforms. The platforms rely on empirical intracellular selection to discover protein interaction modulators. These can discover compounds that disrupt a specific protein-protein interaction (PPI), or achieve the inverse, and bring an E3 ubiquitin ligase and a neosubstrate of interest together to achieve functional protein degradation. In addition to external discovery collaborations, the platforms have generated an internal oncology pipeline focused on unique mechanisms of action around genetically validated targets.

#SimilarOrganizations #People #Financial #Website #More

SYNTHEX

Social Links:

Industry:
Biotechnology Life Science Pharmaceutical Therapeutics

Founded:
2016-01-01

Address:
San Francisco, California, United States

Country:
United States

Website Url:
http://www.synthexlabs.com

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
11.58 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon HSTS Content Delivery Network DMARC Google Apps For Business Google


Similar Organizations

arctic-therapeutics-logo

Arctic Therapeutics

Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.

aro-biotherapeutics-logo

Aro Biotherapeutics

Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.

carisma-therapeutics-logo

Carisma Therapeutics

Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.

imvax-logo

Imvax

Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.

iroko-pharmaceuticals-logo

Iroko Pharmaceuticals

Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.

longevity-biotech-logo

Longevity Biotech

Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.

navrogen-logo

Navrogen

Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.

pinpoint-therapeutics-logo

Pinpoint Therapeutics

Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.

vintabio-logo

VintaBio

VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.


Current Advisors List

francisco-gimenez_image

Francisco Gimenez Board Observer @ SyntheX
Board_observer
2017-05-01

robert-williamson_image

Robert Williamson Senior Adviser @ SyntheX
Advisor
2022-02-01

Current Employees Featured

maria-soloveychik_image

Maria Soloveychik
Maria Soloveychik Chief Executive Officer & Co-Founder @ SyntheX
Chief Executive Officer & Co-Founder
2016-01-01

not_available_image

Tri Luong
Tri Luong Head of Finance and Operations @ SyntheX
Head of Finance and Operations
2017-01-01

charly-chahwan_image

Charly Chahwan
Charly Chahwan Co Founder & Chief Scientific Officer @ SyntheX
Co Founder & Chief Scientific Officer

Founder


charly-chahwan_image

Charly Chahwan

maria-soloveychik_image

Maria Soloveychik

Investors List

bristol-myers-squibb_image

Bristol-Myers Squibb

Bristol-Myers Squibb investment in Corporate Round - SyntheX

sosv_image

SOSV

SOSV investment in Convertible Note - SyntheX

synbio-axlr8r_image

IndieBio

IndieBio investment in Convertible Note - SyntheX

sosv_image

SOSV

SOSV investment in Convertible Note - SyntheX

synbio-axlr8r_image

IndieBio

IndieBio investment in Convertible Note - SyntheX

morgan-noble_image

Morgan Noble

Morgan Noble investment in Seed Round - SyntheX

8vc_image

8VC

8VC investment in Seed Round - SyntheX

sosv_image

SOSV

SOSV investment in Seed Round - SyntheX

oriza-ventures_image

Oriza Ventures

Oriza Ventures investment in Seed Round - SyntheX

sosv_image

SOSV

SOSV investment in Convertible Note - SyntheX

Official Site Inspections

http://www.synthexlabs.com Semrush global rank: 8.63 M Semrush visits lastest month: 604

  • Host name: 191.96.144.74
  • IP address: 191.96.144.74
  • Location: Santiago Chile
  • Latitude: -33.4513
  • Longitude: -70.6653
  • Timezone: America/Santiago

Loading ...

More informations about "SyntheX"

Syntex Labs

Innovation and power in every dose. At Syntex Labs, we are committed to developing peptides and hormonal supplements of the highest quality, specifically designed for professional and โ€ฆSee details»

Synthex Labs - 2025 Company Profile - Tracxn

Synthex Labs - Peptide therapeutics for cancer and rare diseases. Raised a total funding of $10.4M over 3 rounds from 6 investors. Founded by Charly Chahwan and Maria Soloveychik โ€ฆSee details»

SyntheX 2025 Company Profile: Valuation, Funding & Investors

Information on valuation, funding, cap tables, investors, and executives for SyntheX. Use the PitchBook Platform to explore the full profile.See details»

SyntheX Company Profile - Office Locations, Competitors ... - Craft

SyntheX is a company that specializes in synthetic biology. It provides ToRPPIDO and ToRNeDO, selection platforms helping to create and identify molecules that disrupt previously โ€ฆSee details»

Syntex Labs Careers and Employment | Indeed.com

Jul 3, 2013 Find out what works well at Syntex Labs from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for popular โ€ฆSee details»

SyntheX - LinkedIn

SyntheX | 1,359 followers on LinkedIn. Targeting the undruggable with synthetic biology-based drug discovery platforms | SyntheX uses synthetic biology to create the next generation of โ€ฆSee details»

SyntheX - VentureRadar

"SyntheX is expanding drug design into the โ€˜undruggableโ€™ space for the treatment of cancer and rare diseases. We implement an innovative platform for the accelerated discovery of new โ€ฆSee details»

SyntheX Company Overview, Contact Details & Competitors | LeadIQ

Dec 29, 2023 Frequently Asked Questions Where is SyntheX 's headquarters located? SyntheX 's main headquarters is located at 455 Mission Bay Blvd S Suit 145 San Francisco, California โ€ฆSee details»

SyntheX - Products, Competitors, Financials, Employees, โ€ฆ

The end of last year, however, brought about a new test for the sector. Just as global supply chains returned to normal, the Houthis, a Shia Islamist political and military organization that โ€ฆSee details»

Syntex Labs

Nuestros Productos. En Syntex Labs, ofrecemos una gama de productos diseñados para apoyar el rendimiento físico de nuestros usuarios. Desde péptidos hasta suplementos hormonales, โ€ฆSee details»

SyntheX, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Mar 6, 2025 The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is โ€ฆSee details»

Founder Stories: an Interview with Maria from SyntheX Labs

Jun 23, 2016 Maria Soloveychik is the CEO and co-founder of SyntheX Labs, a biotech company developing peptide therapeutics for cancer and other rare diseases.. A: Tell me โ€ฆSee details»

SyntheX Employee Directory, Headcount & Staff | LeadIQ

SyntheX Employee Directory . Biotechnology Research California, United States 11-50 Employees. SyntheX uses synthetic biology to create the next generation of drug discovery โ€ฆSee details»

Torppido - SyntheX

We configured ToRFLEx to address the challenging task of empirically discovering functional Protein-Protein Interaction (PPI) disruptors with our ToRPPIDO strategy. Our unbiased system โ€ฆSee details»

Founder Stories: From academia to building biotech with Maria โ€ฆ

Jun 23, 2016 Maria Soloveychik is the CEO and co-founder of SyntheX Labs, a biotech company developing peptide therapeutics for cancer and other rare diseases. M: So it started โ€ฆSee details»

Pipeline - SyntheX

Our internal pipeline is focused on oncology. We select genetically validated targets based on the concepts of oncogene addiction and synthetic lethality.See details»

SyntheX - IndieBio - #1 in Early Stage Biotech

SyntheX is expanding drug design into the โ€˜undruggableโ€™ space for the treatment of cancer and rare diseases. They implement an innovative platform for the accelerated discovery of new โ€ฆSee details»

3 Dynamos Behind Syntex's Success | The Scientist

When I started Syntex Pharmaceuticals in Britain nearly a quarter of a century ago, the triumvirate to whom I reported in Mexico were all youngish scientists themselves, and all paper โ€ฆSee details»

Synthex Technologies 2025 Company Profile: Valuation, Funding ...

Synthex Technologies General Information Description. Operator of a chemical company intended to offer a wide range of services related to synthesis. The company aims to offer custom โ€ฆSee details»

SyntheX and BMS Partner on Drug Development Deal Worth up to โ€ฆ

It has been almost six years since I backed Maria Soloveychik and Charly Chahwan, founders of SyntheX, for an idea to invent a new way to find and make cancer drugs.See details»

linkstock.net © 2022. All rights reserved